Insurers caution shareholders about bad PR, AI risks, tariffs
Major insurers are warning investors about three emerging threats: negative publicity over claims denials, operational risks from AI for Insurance systems, and potential tariff increases.
The warnings surfaced during recent shareholder meetings and regulatory filings. Insurers flagged concerns that generative AI and LLM technologies could amplify reputational damage if systems make high-profile errors or behave unpredictably.
What insurers told shareholders
Companies emphasized that AI deployment carries execution risk. Poorly designed systems could deny valid claims, trigger regulatory scrutiny, or generate negative media coverage that damages brand trust.
Tariff exposure emerged as a secondary concern. Insurers flagged potential cost increases if import duties rise on medical devices and supplies, which could compress margins in health insurance lines.
The PR risk centers on prior authorization denials and claims processing. Insurers acknowledged that high-profile cases of wrongful denials-whether handled by staff or algorithms-can trigger state investigations and consumer backlash.
Regulatory pressure mounting
State regulators have intensified scrutiny of insurer practices. Several states have launched investigations into prior authorization timelines and payment rates to providers, creating additional compliance costs.
The combination of regulatory pressure and public attention has made insurers more cautious about how they communicate AI investments to the market. Some have scaled back public statements about automation benefits.
Insurers continue deploying AI for claims processing and underwriting but are building in additional oversight layers to catch errors before they reach customers.
Your membership also unlocks:
